Seeing Is Believing
Currently out of the existing stock ratings of Emmanuel Papadakis, 29 are a SELL (27.1%), 40 are a HOLD (37.38%), 38 are a BUY (35.51%).
Analyst Emmanuel Papadakis works at DEUTSCHE BANK with a stock forecast success ratio of 51.47% fulfilled within 111.92 days on average.
Emmanuel Papadakis’s has documented 205 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 08-Feb-2024.
Analyst best performing recommendations are on ALVO (ALVOTECH).
The best stock recommendation documented was for MRNA (MODERNA) at 3/7/2022. The price target of $155 was fulfilled within 9 days with a profit of $28.54 (22.57%) receiving and performance score of 25.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
80
$8.8 (12.36%)
83
2 months 14 days ago
0/3 (0%)
$19.52 (32.28%)
Hold
2 months 18 days ago
0/11 (0%)
$82.61 (131.40%)
Buy
85
$13.8 (19.38%)
3 months 3 days ago
0/11 (0%)
$19.26 (29.30%)
Hold
70
$-1.2 (-1.69%)
3 months 23 days ago
5/5 (100%)
$2.71 (4.03%)
224
Buy
142.74
9 months 14 days ago
0/6 (0%)
$75.62 (112.66%)
Which stock is Emmanuel Papadakis is most bullish on?
Which stock is Emmanuel Papadakis is most reserved on?
What Year was the first public recommendation made by Emmanuel Papadakis?